4.6 Article

Concordant Association of Insulin Degrading Enzyme Gene (IDE) Variants with IDE mRNA, Aβ, and Alzheimer's Disease

Journal

PLOS ONE
Volume 5, Issue 1, Pages -

Publisher

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pone.0008764

Keywords

-

Funding

  1. National Institutes of Health [R01 AG18023, KL2 RR024151]
  2. National Institute on Aging [AG25711, AG17216, AG03949, U24 AG21886, F32 AG20903]
  3. Mayo Alzheimer's Disease Research Center [P50 AG16574]
  4. Mayo Alzheimer's Disease Patient Registry [U01 AG06576]
  5. Robert and Clarice Smith Postdoctoral Fellowship
  6. Robert and Clarice Smith and Abigail Van Buren Alzheimer's Disease Research Program
  7. Palumbo Professorship in Alzheimer's Disease Research
  8. Johnnie B. Byrd and Siragusa Foundation
  9. Medical Research Council UK [108-1080315-0302]
  10. European Commission [018947 LSHG-CT-2006-01947]
  11. Alzheimer's Research Trust
  12. Charles Wolfson Charitable Trust
  13. Norman Collisson Foundation
  14. Alzheimer's Research Trust and Merck and Co. Inc.
  15. MRC [MC_U127561128] Funding Source: UKRI
  16. Alzheimers Research UK [ART-BIG2009-1, ART-NCG2008A-1, ART-NCG2006-1, ART-SB2010A-1, ART-PPG2008A-3] Funding Source: researchfish
  17. Medical Research Council [MC_U127561128, G0700704B] Funding Source: researchfish

Ask authors/readers for more resources

Background: The insulin-degrading enzyme gene (IDE) is a strong functional and positional candidate for late onset Alzheimer's disease (LOAD). Methodology/Principal Findings: We examined conserved regions of IDE and its 10 kb flanks in 269 AD cases and 252 controls thereby identifying 17 putative functional polymorphisms. These variants formed eleven haplotypes that were tagged with ten variants. Four of these showed significant association with IDE transcript levels in samples from 194 LOAD cerebella. The strongest, rs6583817, which has not previously been reported, showed unequivocal association (p = 1.5 x 10(-8), fold-increase = 2.12,); the eleven haplotypes were also significantly associated with transcript levels (global p = 0.003). Using an in vitro dual luciferase reporter assay, we found that rs6583817 increases reporter gene expression in Be(2)-C (p = 0.006) and HepG2 (p = 0.02) cell lines. Furthermore, using data from a recent genome-wide association study of two Croatian isolated populations (n = 1,879), we identified a proxy for rs6583817 that associated significantly with decreased plasma A beta 40 levels (beta = 20.124, p = 0.011) and total measured plasma A beta levels (b = 20.130, p = 0.009). Finally, rs6583817 was associated with decreased risk of LOAD in 3,891 AD cases and 3,605 controls. (OR = 0.87, p = 0.03), and the eleven IDE haplotypes (global p = 0.02) also showed significant association. Conclusions: Thus, a previously unreported variant unequivocally associated with increased IDE expression was also associated with reduced plasma A beta 40 and decreased LOAD susceptibility. Genetic association between LOAD and IDE has been difficult to replicate. Our findings suggest that targeted testing of expression SNPs (eSNPs) strongly associated with altered transcript levels in autopsy brain samples may be a powerful way to identify genetic associations with LOAD that would otherwise be difficult to detect.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available